PENTAMAKS Trademark

Trademark Overview

On Monday, July 17, 2000, a trademark application was filed for PENTAMAKS with the United States Patent and Trademark Office. The USPTO has given the PENTAMAKS trademark a serial number of 76090956. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, January 3, 2014. This trademark is owned by N.V. ORGANON. The PENTAMAKS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

CONDUCT OF CLINICAL TRIALS IN THE AREA OF MEDICAL SCIENCE
pentamaks

General Information

Serial Number76090956
Word MarkPENTAMAKS
Filing DateMonday, July 17, 2000
Status710 - CANCELLED - SECTION 8
Status DateFriday, January 3, 2014
Registration Number2718432
Registration DateTuesday, May 27, 2003
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 11, 2001

Trademark Statements

Goods and ServicesCONDUCT OF CLINICAL TRIALS IN THE AREA OF MEDICAL SCIENCE

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, January 3, 2014
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type32 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB
Party NameSANOFI-SYNTHELABO
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressPARIS 75013
FR
Party NameN.V. ORGANON
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
Address5349 AB Oss
NL
Party NameN.V. ORGANON
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
Address5349 AB Oss
NL
Party NameN.V. ORGANON
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
Address5349 AB Oss
NL

Trademark Events

Event DateEvent Description
Friday, January 3, 2014CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Thursday, October 7, 2010ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, October 7, 2010TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 12, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, October 29, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, June 4, 2009REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, May 29, 2009ASSIGNED TO PARALEGAL
Tuesday, May 26, 2009TEAS SECTION 8 & 15 RECEIVED
Wednesday, May 20, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 20, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, May 7, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, May 7, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 18, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, March 18, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, January 18, 2008CASE FILE IN TICRS
Wednesday, February 23, 2005ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, February 23, 2005TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 15, 2004TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 27, 2003REGISTERED-PRINCIPAL REGISTER
Monday, March 31, 2003Sec. 1(B) CLAIM DELETED
Wednesday, September 4, 2002NOTICE OF ALLOWANCE CANCELLED
Monday, March 31, 2003REINSTATED
Sunday, February 2, 2003ABANDONMENT - NO USE STATEMENT FILED
Friday, September 6, 2002PAPER RECEIVED
Tuesday, March 5, 2002NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 11, 2001PUBLISHED FOR OPPOSITION
Wednesday, November 21, 2001NOTICE OF PUBLICATION
Sunday, August 12, 2001APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, August 3, 2001ASSIGNED TO EXAMINER
Monday, June 4, 2001CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 1, 2001LETTER OF SUSPENSION MAILED
Wednesday, December 27, 2000ASSIGNED TO EXAMINER

Related Keywords

pentamaks medical science area trials clinical conduct